GM said in announcing the spending that more details on the new engine and automatic transmission would be coming later. It likely would be the first 10-speed transmission.
While 6, 7 and 8 speeds increasingly in common use to improve fuel mileage, Jeep and Land Rover just rolled out the first production 9-speed automatics. GM will see that and raise it one with its new gearbox.
The plants getting the upgrades are located in Detroit, Flint and Romulus, Mich.; Toledo, Ohio and Bedford, Ind. and GM says the spending also will create or retain about 1,000 jobs.
While the headline items are the new, more fuel-efficient V-6 and 10-speed transmission, the updates also will support production of an existing 6-speed transmission and pay for plant improvements, including a new paint shop and logistics center, GM says.
Top 5 Biotech Companies To Watch In Right Now: Leggett & Platt Incorporated(LEG)
Leggett & Platt, Incorporated designs and produces various engineered components and products worldwide. Its Residential Furnishings segment offers bedding components, such as innersprings and wire forms; furniture components, including steel mechanisms, springs, seat suspensions, steel tubular seat frames, bed frames, ornamental beds, and power foundations; and structural fabrics, carpet underlay materials, and geo components. This segment serves manufacturers of finished bedding products or upholstered furniture. The company?s Commercial Fixturing & Components segment provides shelving, counters, showcases, and garment racks; standardized shelvings; point-of-purchase displays; and bases, columns, back rests, casters, and frames. This segment offers its products to retail chains and specialty shops; brand name marketers; distributors of consumer products; and office, institutional, and commercial furniture manufacturers. Its Industrial Materials segment provides steel rod s, drawn wires, steel billets, fabricated wire products, welded steel tubing, and fabricated tube components to bedding and furniture, and mechanical spring makers; automotive seating, and lawn and garden equipment manufacturers; and waste recyclers, waste removal businesses, and medical supply businesses. The company?s Specialized Products segment offers manual and power lumbar support and massage systems; seat suspension systems; automotive control cables; low voltage motors; actuation assemblies; formed metal and wire components; quilting machines; machines for shaping wire into springs; industrial sewing/finishing machines; van interiors; and docking stations, as well as specialty trailers for telephone, cable, and utility companies. It serves bedding and automobile seating manufacturers. The company sells its products through its sales representatives and distributors. Leggett & Platt, Incorporated was founded in 1883 and is based in Carthage, Missouri.
Advisors' Opinion:- [By Oliver Pursche]
I think the first step will be an increase in share-buybacks and an increase in dividends. As such, I am once again overweighting large-cap multinationals, including some great European names. My favorites include Novartis (NVS) , Legget and Platt (LEG) and Visa (V) .� Of course, the potential risk is that the cash horde remains and even grows, likely creating a deeper negative interest rate environment ��something that surely would be damaging to our economy.
- [By Reuben Brewer]
Leggett & Platt (NYSE: LEG ) , best known for making bed springs, is another company making a strategic shift. Over the last few years, the company has been selling off smaller and less desirable operations to focus on growth businesses. That's led to what should be a temporary slowdown on the top and bottom lines and a relatively depressed stock price.
- [By Holly LaFon]
Leggett & Platt (LEG) is a leading manufacturer of engineered products and components. As the pioneer of steel coil springs found in mattresses and furniture, the company continues to supply a variety of components to bedding and furniture manufacturers. Additionally, Leggett & Platt's broader product line includes retail store fixtures, office furniture components, automotive seating components and industrial steel wire and tubing. Customers choose Leggett & Platt as a supplier because the company's manufacturing scale and processes result in lower costs than customers can produce themselves. We believe earnings should grow based on the contribution of new products, cost reduction efforts and the improving housing market. Moreover, future dividend growth appears likely based on a 42-year record of dividend increases. We believe Leggett & Platt is an attractive investment based on its 3.8% dividend yield and positive growth outlook.
- [By Dividends4Life]
Linked here is a detailed quantitative analysis of Leggett & Platt Inc. (LEG). Below are some highlights from the above linked analysis:
Company Description: Leggett & Platt Inc. makes a broad line of bedding and furniture components and other home, office and commercial furnishings, as well as products for non-furnishings markets.
Top Logistics Stocks To Own Right Now: Penn National Gaming Inc.(PENN)
Penn National Gaming, Inc. and its subsidiaries own and manage gaming and pari-mutuel properties in the United States. It operates approximately 27,000 gaming machines; 500 table games; and 2,000 hotel rooms in 23 facilities in 16 jurisdictions, including Colorado, Florida, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Mississippi, Missouri, New Jersey, New Mexico, Ohio, Pennsylvania, West Virginia, and Ontario. The company was formerly known as PNRC Corp. and changed its name to Penn National Gaming, Inc. in 1994. Penn National Gaming, Inc. was founded in 1982 and is based in Wyomissing, Pennsylvania.
Advisors' Opinion:- [By Will Ashworth]
Famed investor Leon Cooperman sold his position in Penn National Gaming (PENN) in the fourth quarter of 2013, replacing it with a 2.2 million shares of GLPI, the real estate spinoff the casino operator took public through a 1-for-1 share distribution last November. Its first acquisition came one month later when it paid $140 million for a casino in East St. Louis. Pure-play REITs come in all shapes and sizes, but never before has there been one in the casino business.
Top Logistics Stocks To Own Right Now: Nyxio Technologies Corp (NYXO)
Nyxio Technologies Corporation, incorporated on June 08, 2006, through its wholly owned subsidiary Nyxio Technologies Inc. (Nyxio), develop and provide technology for the entertainment and commercial markets within the consumer electronic industry. The Company�� product includes VioSphere Smart television (TV), a flat screen TV with a fully integrated personal computer.
The Realm is an all in one personal computer (PC)/ TV, combining the latest in PC technology with high definition (HD) TV. The Realm Pro, which is all in One PC/TV geared for commercial and digital signage markets. Venture MMV, which is a mobile media viewer is a new class of video eyewear offering designer styling in a sleek ergonomic design with features and performance. The Vuzion is a TV with Android operating system (OS) built in enabling 400,000 Android applications on a TV.
The Company competes with Sony, Samsung, LG, Vizio, Apple, Dell, and HP.
Advisors' Opinion:- [By Peter Graham]
Nyxio Technologies Corp (OTCMKTS: NYXO), COREwafer Industries Inc (OTCMKTS: WAFR) and NanoTech Entertainment, Inc (OTCMKTS: NTEK) are three small cap stocks in some very diverse industries. In fact, one of these stocks just bought a 3D ice sculpture business. So will investors see their investment melt with that small cap stock�along with the other two? Here is a closer look to help you decide for yourself:��
Top Logistics Stocks To Own Right Now: Bio-Path Holdings Inc (BPTH)
Bio-Path Holdings Inc is a development stage company. The Company, through its wholly owned subsidiary, Bio-Path, Inc. is engaged in the business of developing cancer therapeutics. As of December 31, 2011, the Company had licenses from The University of Texas M. D. Anderson Cancer Center (MD Anderson) for three lead products and nucleic acid delivery technology, including tumor targeting technology. The licenses provide drug delivery platform technology with composition of matter intellectual property for antisense that enables systemic delivery of antisense, formulation intellectual property for systemic delivery of small interfering Ribonucleic acid (RNA) (siRNA) and small molecules for treatment of cancer. The Company issued a press release announcing that the United States Food and Drug Administration (FDA) had allowed an IND (investigational new drug) for its lead cancer drug candidate liposomal BP-100-1.01 (or Liposomal Grb-2 or L-Grb-2) to proceed into clinical trials.
In February, 2012, the Company completed requirements for treating patients in the second cohort. The dose being used for treatment in the third cohort is double the dose that was used to treat patients in the second cohort. At the end of February, 2012, enrollment continued in the third cohort of the clinical trial and patients are being treated.
BP-100-1.01
BP-100-1.01 is the Company's lead lipid delivery antisense drug candidate, which is being clinically tested in patients having acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS) and acute lymphoblastic leukemia (ALL). Receipt of an IND allowed the Company to commence its Phase I clinical trial to study L-Grb-2 in human patients. Phase I clinical trial is a dose-escalating study to determine the safety and tolerance of escalating doses of L-Grb-2. The clinical trial is being conducted at The University of Texas MD Anderson Cancer Center. As of December 31, 2011, the trial is in the middle of ! testing the third dose in patients.
BP-100-2.01
BP-100-1.02 is Liposomal Bcl-2 (also L-Bcl-2), another liposomal antisense drug candidate that was licensed from MD Anderson. This drug has pre-clinical testing data package. The target protein for this drug candidate, Bcl-2, is involved in regulating programmed cell death. In cancer, the Bcl-2 protein can over-express, which can lead to a situation, in which the Bcl-2 protein blocks the cell�� normal death signals, making the cancer cell resistant to chemotherapy. Types of cancer potentially treatable with L-Bcl-2 include lymphoma, prostate cancer, small cell lung cancer, breast cancer, melanoma, chronic lymphoid leukemia (CLL) and several others.
Advisors' Opinion:- [By Lisa Levin]
Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.
No comments:
Post a Comment